Skip to Content

Join the 'Lung Cancer' group to help and get support from people like you.

Lung Cancer News

Related terms: Cancer, Bronchogenic Carcinoma, Cancer, Lung

FDA Approves Keytruda (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Posted 4 days ago by Drugs.com

KENILWORTH, N.J.--(BUSINESS WIRE) October 30, 2018 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with carboplatin and either paclitaxel or nab-paclitaxel, for the first-line treatment of patients with metastatic squamous non-small cell lung c ...

FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer

Posted 13 days ago by Drugs.com

November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for ...

Lung Cancer Risk Tied to Common Blood Pressure Drugs, ACE Inhbitors

Posted 25 Oct 2018 by Drugs.com

WEDNESDAY, Oct. 24, 2018 – Millions of Americans take angiotensin-converting enzyme (ACE) inhibitors to lower their blood pressure, but a new study suggests they might also increase their odds of developing lung cancer. Among people taking these drugs for more than five years, the increased risk may be as high as 14 percent. Although that seems a small number, it could represent a large number ...

FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer

Posted 27 Sep 2018 by Drugs.com

September 27, 2018 - Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Vizimpro [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an ...

Many Who Battle Cancer Stay Strong Mentally

Posted 4 Sep 2018 by Drugs.com

TUESDAY, Sept. 4, 2018 – Most older adults who are current or former cancer patients have good mental health, a new study finds. The study included 438 Canadian adults with cancer and 1,174 cancer survivors who took part in a 2012 survey on mental health. All were aged 50 and older. Two-thirds of the current cancer patients and more than three-quarters of former cancer patients had good mental ...

Chemo for Lung Cancer May Trigger Early Menopause, Study Finds

Posted 4 Sep 2018 by Drugs.com

TUESDAY, Sept. 4, 2018 – Younger women who undergo chemotherapy for lung cancer are more likely to experience early menopause, researchers have found. The new study included 182 women who were an average age of 43 when they were diagnosed with lung cancer. Within a year, 64 percent of the 85 women who received systemic chemotherapy had entered menopause, compared with 15 percent of the 94 women ...

Health Tip: Talking About Your Cancer Diagnosis

Posted 28 Aug 2018 by Drugs.com

-- If you've been diagnosed with cancer, your family and close friends can be a great source of physical and moral support. The American Cancer Society suggests how to tell loved ones about your diagnosis: Don't wait to tell them. Sooner or later, they'll all know. They might feel hurt or left out if they haven't heard about it from you. Explain what type of cancer you have and how it will be ...

When a Parent Has Cancer, Kids Suffer Long Term: Study

Posted 21 Aug 2018 by Drugs.com

TUESDAY, Aug. 21, 2018 – Children whose parents have cancer are more likely to struggle in school and to have lower incomes as adults, a new Danish study suggests. The study included more than 1 million people born in Denmark from 1978 through 1999. Before their 18th birthday, about one in 20 had a parent diagnosed with cancer. By age 15, those kids had lower grade averages in school than their ...

FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer

Posted 21 Aug 2018 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE)--August 17, 2018 – Bristol-Myers Squibb Company (NYSE:BMY) today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA) as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other ...

Lung Cancer Screening's Downside Not Discussed Enough

Posted 13 Aug 2018 by Drugs.com

MONDAY, Aug. 13, 2018 – The potential risks of lung cancer screening are often left out when doctors and patients discuss the issue, a new report suggests. Early detection of lung cancer can save lives, and lung cancer screening is recommended for high-risk current and former smokers. But the U.S. Preventive Services Task Force and other organizations say that doctors need to explain the risks ...

For Women Worldwide, Lung Cancers Rise as Breast Cancers Decline

Posted 1 Aug 2018 by Drugs.com

WEDNESDAY, Aug. 1, 2018 – As women around the world wage war against cancer, good news on the breast cancer front is tempered by predictions that lung cancer deaths could rise more than 40 percent. Researchers in Spain reported that between 2015 and 2030, lung cancer deaths among women worldwide will likely increase 43 percent. During that same period, however, breast cancer deaths are projected ...

Could a Blood Test Spot Lung Cancer Early?

Posted 4 Jun 2018 by Drugs.com

SATURDAY, June 2, 2018 – Genetic blood testing is showing potential as a means of catching some early stage cancers, researchers are reporting. For example, a panel of three different genetic tests was able to detect early stage lung cancer about half of the time in people who'd already been diagnosed with the disease. The tests also detected late-stage lung cancers about 9 out of 10 times, the ...

Cancer Drug Keytruda a New Weapon Against Advanced Lung Tumors

Posted 4 Jun 2018 by Drugs.com

SUNDAY, June 3, 2018 – A cancer drug that boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows. Keytruda (pembrolizumab) extended life four to eight months longer than chemotherapy in lung cancer patients whose immune systems had been duped by their cancer cells. "This trial shows that pembrolizumab used alone improves survival as opposed to ...

Cancer Care Twice as Costly in U.S. Versus Canada

Posted 1 Jun 2018 by Drugs.com

FRIDAY, June 1, 2018 – What a difference a border makes, when it comes to the cost of cancer care. Common chemotherapy for advanced colorectal cancer costs twice as much in Washington state as it does a short walk across the Canadian border into British Columbia, researchers report. A month's worth of chemotherapy cost $12,345 on the U.S. side of the border versus $6,195 just over the line into ...

Lung Cancer Rate Now Higher in Young Women Than Young Men

Posted 24 May 2018 by Drugs.com

WEDNESDAY, May 23, 2018 – In a reversal of historical patterns, lung cancer is now more common among young U.S. women than men, a new study finds. The good news, researchers found, is that over the past two decades, lung cancer rates among 35- to 54-year-old Americans have dropped across the board. But the decline has been steeper among men so that now, incidence of the disease is higher in ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma, Cancer